Recruiting Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers NCT05884320 Conditions Gland, Head and Neck Neoplasms, Mouth Diseases, +7 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
